Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://chiaraugtt305448.getblogs.net/71421157/trelaglutide-exploring-a-new-therapy-for-chronic-diseases